These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 7711869)
21. Antibody panel in diagnosis of lymphoid neoplasms. Vassallo J; Pinto GA J Clin Pathol; 1998 Aug; 51(8):638-9. PubMed ID: 9828829 [No Abstract] [Full Text] [Related]
22. [Use of immunohistochemical markers in the diagnosis of carcinoma of the breast]. Bussolati G Minerva Chir; 1988 Sep; 43(18 Suppl):5-7. PubMed ID: 3226595 [No Abstract] [Full Text] [Related]
23. Neuroendocrine carcinomas: role of immunocytochemistry and electron microscopy. Hammond EH; Yowell RL; Flinner RL Hum Pathol; 1998 Dec; 29(12):1367-71. PubMed ID: 9865821 [TBL] [Abstract][Full Text] [Related]
24. [Expression of intermediate filament and oncogene proteins in squamous cell carcinomas of the oral cavity. Correlation of differentiation]. Störkel S; Moll R; Reichert T; Gillenkirch R; Spitz S; Wagner W Dtsch Z Mund Kiefer Gesichtschir; 1991; 15(5):360-2. PubMed ID: 1816968 [TBL] [Abstract][Full Text] [Related]
25. Identification of tumor-associated antigens as diagnostic and predictive biomarkers in cancer. Zhang JY; Looi KS; Tan EM Methods Mol Biol; 2009; 520():1-10. PubMed ID: 19381943 [TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical study of melanocytic differentiation antigens in cutaneous malignant melanoma. A comparison of six commercial antibodies and one non-commercial antibody in nodular melanoma, superficially spreading melanoma and lentigo maligna melanoma. Kocan P; Jurkovic I; Böör A; Dudríková K; Krajcár R; Benický M; Kromydaki A Cesk Patol; 2004 Apr; 40(2):50-6. PubMed ID: 15233017 [TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical and ultrastructural localization of T antigen in ovarian tumors. Ghazizadeh M; Oguro T; Sasaki Y; Aihara K; Araki T; Springer GF Am J Clin Pathol; 1990 Mar; 93(3):315-21. PubMed ID: 1689937 [TBL] [Abstract][Full Text] [Related]
28. Tumor markers: from laboratory to clinical utility. Schrohl AS; Holten-Andersen M; Sweep F; Schmitt M; Harbeck N; Foekens J; Brünner N; Mol Cell Proteomics; 2003 Jun; 2(6):378-87. PubMed ID: 12813140 [No Abstract] [Full Text] [Related]
29. Immunohistochemistry in the differential diagnosis of soft tissue tumors. Brooks JS Monogr Pathol; 1996; 38():65-128. PubMed ID: 8744275 [TBL] [Abstract][Full Text] [Related]
30. Immunohistochemistry of solid tumors. Brief review of selected problems. Miettinen M APMIS; 1990 Mar; 98(3):191-9. PubMed ID: 1690556 [TBL] [Abstract][Full Text] [Related]
31. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas. Tot T Cancer; 2001 Nov; 92(10):2727-32. PubMed ID: 11745209 [TBL] [Abstract][Full Text] [Related]
32. [Possibilities, failures and prospects of studies on tumor markers in oncological clinics. 1. (lecture)]. Kushlinskiĭ NE Klin Lab Diagn; 1999 Apr; (4):25-32. PubMed ID: 10356902 [No Abstract] [Full Text] [Related]
36. Differentiation of the major human tumor groups using conventional and monoclonal antibodies specific for individual intermediate filament proteins. Osborn M; Altmannsberger M; Debus E; Weber K Ann N Y Acad Sci; 1985; 455():649-68. PubMed ID: 2417533 [No Abstract] [Full Text] [Related]